Long-Term Outcomes of a Japanese Prospective Multicenter Registry Using a Heparin-Bonded Expanded Polytetrafluoroethylene Graft for Above-the-Knee Femoropopliteal Bypasses

CONCLUSIONS: This multicenter prospective registry-based analysis showed sustained excellent clinical improvement and secondary patency for up to 8 years following PROPATEN®-based AKFPB. PROPATEN®constitutes a durable and good revascularization option for complex superficial femoral artery lesions, especially when endovascular treatment is inappropriate or an adequate venous conduit is unavailable.PMID:38616124 | DOI:10.1253/circj.CJ-24-0135

Source: Circulation Journal - April 14, 2024 Category: Cardiology Authors: Naoki Fujimura Hideaki Obara Kentaro Matsubara Naoki Toya Naoko Isogai Hidemitsu Ogino Taku Fujii Toshifumi Kudo Yuji Kanaoka Hirohisa Harada Hidetoshi Uchiyama Atsushi Guntani Tatsuya Shimogawara Susumu Watada Shintaro Shibutani Takao Ohki Japanese Bypas Source Type: research